Axon Neuroscience Is A Clinical Stage Biotech Company Based In Bratislavaslovakiafounded In 1999 By Professor Michal Novaikthe Company Focuses On Developing Disease Modifying Immunotherapies For Alzheimer S Disease And Other Tauopathiesspecifically Targeting Tau Proteinsaxon Employs Between 51 And 200 People And Has A Mission To Enhance The Health And Quality Of Life For Patients Through Innovative Therapeutic Approaches The Company S Lead Products Include Aadvac1A First In Man Tau Vaccine Aimed At Addressing Critical Needs In Alzheimer S Treatmentand Aadvac2A Monoclonal Antibody Targeting Tau Proteinsadditionallyaxon Is Developing Diagnostic Assays To Accurately Identify Patients With Tau Related Brain Diseaseswith A Revenue Range Of $10 Million To $50 Millionaxon Neuroscience Is Positioned For Growth In The Biotech Sectorsupported By A Dedicated Scientific Team With Over 20 Years Of Experience In Alzheimer S Research
